港股異動 | 雷蛇(1337.HK)漲近6% 香港區總經理指公司部分產品銷售有明顯增長
格隆匯7月13日丨雷蛇(1337.HK)現報1.65港元,漲幅5.77%,最新總市值147.3億港元。公司香港區總經理郭美琪指出,受新型冠狀病毒疫情影響,在家工作需求增加,間接令公司受惠,因為用户足不出户,對硬件的需求有所增加,特別是串流鏡頭及直播麥克風等銷售均有明顯增長,而軟件業務方面日活躍用户亦有所提升,她指出公司在電商方面收入有所增長,而在“宅經濟”的推動下Razer Gold使用量及Razer Fintech B2B的支付處理業務亦錄得升勢。在香港市場方面,她指出本地線上店增長達雙位數,而旗下門店的表現亦符合預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.